{
    "eid": "2-s2.0-85085342488",
    "title": "Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways",
    "cover-date": "2020-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Biological Psychiatry",
            "@code": "2803",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Chronic fatigue syndrome",
        "Cytokines",
        "Fibromyalgia",
        "Inflammation",
        "Myalgic encephalomyelitis",
        "Neuroimmunomodulation"
    ],
    "authors": [
        "Abbas F. Almulla",
        "Hussein Kadhem Al-Hakeim",
        "Mokhlad Swadi Abed",
        "Andre F. Carvalho",
        "Michael Maes"
    ],
    "citedby-count": 10,
    "ref-count": 77,
    "ref-list": [
        "Development of a novel neuro-immune and opioid-associated fingerprint with a cross-validated ability to identify and authenticate unknown patients with major depression: far beyond differentiation, discrimination, and classification",
        "Construction of a neuro-immune-cognitive pathway-phenotype underpinning the phenome of deficit schizophrenia",
        "The Neuro-immune fingerprint of major neuro-cognitive psychosis or deficit schizophrenia: a supervised machine learning study",
        "Schizophrenia Phenomenology Revisited: Positive and Negative Symptoms Are Strongly Related Reflective Manifestations of an Underlying Single Trait Indicating Overall Severity of Schizophrenia",
        "Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome",
        "Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways",
        "Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome",
        "The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations",
        "Thought, language, and communication in schizophrenia: diagnosis and prognosis",
        "The Cognitive Neuroscience of Thought Disorder in Schizophrenia. The Oxford Handbook of Thinking and Reasoning",
        "Controlling the false discovery rate: a practical and powerful approach to multiple testing",
        "The unscrambler appendices: method references. 2019",
        "Comorbidity investigations of gastrointestinal disorders with mental disorders in patients or animals",
        "Cognitive functioning in chronic fatigue syndrome: a meta-analysis",
        "Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls",
        "From prediction error to psychosis: ketamine as a pharmacological model of delusions",
        "The two-syndrome concept: origins and current status",
        "Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia",
        "Working memory deficits in chronic fatigue syndrome: differentiating between speed and accuracy of information processing",
        "Effects of psychiatric medications on sleep and sleep disorders",
        "Working memory deficits associated with chronic fatigue syndrome",
        "Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder",
        "Program FACTOR at 10: origins, development and future directions",
        "Episodic memory and impairment of an early encoding process in schizophrenia",
        "The assessment of anxiety states by rating",
        "A rating scale for depression",
        "Negative symptoms and cognitive deficits: what is the nature of their relationship?",
        "A psychometric study of the multidimensional fatigue inventory to assess fatigue in patients with schizophrenia spectrum disorders",
        "A factor analysis of chronic fatigue symptoms in a community-based sample",
        "Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning",
        "Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: results of unsupervised machine learning analysis",
        "In schizophrenia, depression, anxiety, and physiosomatic symptoms are strongly related to psychotic symptoms and excitation, impairments in episodic memory, and increased production of neurotoxic tryptophan catabolites: a multivariate and machine learning study",
        "Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "Cognitive impairment in schizophrenia",
        "The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery",
        "Formal thought disorders: from phenomenology to neurobiology",
        "The schedule for the deficit syndrome: an instrument for research in schizophrenia",
        "Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: a BOLD fMRI study of verbal working memory",
        "A general approach for fitting pure exploratory bifactor models",
        "An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways",
        "Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome",
        "Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways",
        "Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs",
        "Increased serum interleukin-8 and interleukin- 10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor",
        "Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability",
        "Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression",
        "In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation",
        "In schizophrenia, deficits in natural IgM Isotype antibodies including those directed to malondialdehyde and azelaic acid strongly predict negative symptoms, neurocognitive impairments, and the deficit syndrome",
        "Is a diagnostic blood test for chronic fatigue syndrome on the horizon?",
        "Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit schizophrenia",
        "Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways",
        "In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde",
        "Methodological problems in identifying and measuring first-rank symptoms of schizophrenia",
        "Cytokine signature associated with disease severity in chronic fatigue syndrome patients",
        "Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics",
        "Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis",
        "The brief psychiatric rating scale",
        "Insomnia is frequent in schizophrenia and associated with night eating and obesity",
        "The assessment of neuropsychological functioning in schizophrenia",
        "SmartPLS 3",
        "Chronic fatigue syndrome and quality of life",
        "Cytokine signatures in chronic fatigue syndrome patients: a case control study and the effect of anakinra treatment",
        "The role of aberrations in the Immune-inflammatory Reflex System (IRS) and the compensatory immune-regulatory reflex system",
        "The role of aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia",
        "Organizational and visual memory deficits in schizophrenia and bipolar psychoses using the Rey-Osterrieth complex figure: effects of duration of illness",
        "A new schizophrenia model: immune activation is associated with induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions",
        "Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients",
        "Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain",
        "Gut microbiota, bacterial translocation, and interactions with diet: pathophysiological links between major depressive disorder and non-communicable medical comorbidities",
        "The macrophage-T-lymphocyte theory of schizophrenia: additional evidence",
        "The challenge of psychiatric nosology and diagnosis",
        "The translational validation as novel approach to integration of neuroscience and psychiatry",
        "The role of negative symptoms and cognitive dysfunction in schizophrenia outcome",
        "Neurocognitive impairments in deficit and non-deficit schizophrenia and their relationships with symptom dimensions and other clinical variables",
        "A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)"
    ],
    "affiliation": [
        {
            "affiliation-city": "Najaf",
            "@id": "60109789",
            "affilname": "The Islamic University, Najaf",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60109789",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Kufa",
            "@id": "60071160",
            "affilname": "University of Kufa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071160",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Baghdad",
            "@id": "60071154",
            "affilname": "Baghdad Teaching Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071154",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        }
    ],
    "funding": []
}